Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |